Revealed: Drug Eluting Balloons Market Set to Transform Cardiovascular Treatments by 2035
With the Drug Eluting Balloons Market projected to attain a valuation of $1.463 billion by 2035, the landscape of cardiovascular treatments is undergoing a seismic shift. This growth trajectory represents a robust compound annual growth rate (CAGR) of 7.50% from its initial estimated value of $0.66 billion in 2024. The extensive adoption of these devices is fueled by the urgent need for...